How Much Does Mastectomy Reduce Breast Cancer Risk?
At a Glance
A preventative mastectomy reduces the risk of developing breast cancer by 90% to 95% for BRCA1 and BRCA2 mutation carriers. While it significantly lowers risk, it does not drop the risk to zero because microscopic amounts of breast tissue cannot be completely removed during surgery.
A bilateral risk-reducing mastectomy (BRRM), often called a preventative mastectomy, lowers the risk of developing breast cancer by approximately 90% to 95% for individuals with a BRCA1 or BRCA2 mutation [1][2]. This makes it the most effective surgical strategy available to prevent breast cancer in high-risk carriers [1].
To put this in perspective: if your lifetime risk of developing breast cancer as a BRCA carrier is around 70%, a preventative mastectomy can reduce that absolute risk down to approximately 1% to 3%.
Why the Risk Is Never Exactly Zero
While a 90% to 95% reduction is life-changing for many patients, it is important to understand why the risk does not drop completely to zero.
It is anatomically impossible for a surgeon to remove 100% of your breast tissue [3]. Breast tissue is not contained in a neat, easily removable capsule; it naturally spreads widely across the chest wall. It can extend high up to your collarbone, over into your armpit (axilla), and down toward your upper abdomen [3].
Because of this natural anatomy, microscopic remnants of breast glandular tissue are usually left behind, often on the underside of the skin flaps or near the nipple and areola [3][4]. This small amount of remaining tissue means you retain about 5% to 10% of your original risk, leaving a very small absolute risk of developing breast cancer in your lifetime (typically around 1% to 3%) [1][5].
Differences Between BRCA1 and BRCA2
While preventative mastectomy drastically reduces the chance of getting breast cancer for both groups, its impact on overall survival differs slightly depending on whether you carry a BRCA1 or BRCA2 mutation:
- BRCA1 Carriers: Studies show that preventative mastectomy not only lowers the incidence of breast cancer but also clearly reduces breast cancer-specific mortality (the risk of dying from breast cancer) compared to close monitoring and imaging [6][7].
- BRCA2 Carriers: The survival benefit is less pronounced [6]. Because breast cancers linked to BRCA2 often grow more slowly and are highly treatable if caught early, intensive surveillance (such as regular MRIs and mammograms) may offer similar overall survival rates compared to preventative surgery [7][8].
Modern Surgical Options and Realities
If you choose to move forward with a mastectomy, there are modern techniques designed to preserve your physical appearance while managing your risk:
- Nipple-sparing mastectomy (NSM): The surgeon removes the breast tissue but leaves the skin, nipple, and areola intact.
- Skin-sparing mastectomy (SSM): The surgeon removes the breast tissue, nipple, and areola, but preserves most of the breast skin to accommodate reconstruction.
Research shows these procedures are highly effective at controlling cancer risk and are considered a safe, valid option for BRCA carriers who want a better cosmetic outcome [9][10].
Understanding the physical costs
While these options preserve appearance, a mastectomy is a major surgery that fundamentally changes your body. It is important to know:
- Loss of sensation: Most patients experience a significant or total loss of physical sensation in their chest and nipples, as the sensory nerves are cut when the breast tissue is removed.
- Breastfeeding: A mastectomy removes the glandular tissue and milk ducts, permanently ending the ability to breastfeed.
- Surgical risks and recovery: Whether you choose implant-based reconstruction or autologous reconstruction (using your own tissue), you will face major physical recovery and potential surgical risks like infection, bleeding, or issues with skin healing.
Choosing between intensive surveillance and surgery is a highly personal decision with no single “right” answer. Discussing these statistics and physical realities with a genetic counselor, breast surgical oncologist, and plastic surgeon can help you decide what makes the most sense for your life and priorities.
Common questions in this guide
Why doesn't a preventative mastectomy eliminate breast cancer risk completely?
Is a preventative mastectomy better for BRCA1 or BRCA2 carriers?
Will I lose physical sensation in my chest after a preventative mastectomy?
Can I still breastfeed after a preventative mastectomy?
What is a nipple-sparing mastectomy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my specific BRCA mutation and family history, what is my estimated absolute lifetime risk of breast cancer if I choose intensive surveillance instead of surgery?
- 2.What surgical techniques (like nipple-sparing) am I a candidate for, and what are the specific risks of those procedures for my body type?
- 3.Do you use any nerve-sparing techniques during a mastectomy, and what are the realistic chances of retaining any physical sensation in my chest?
- 4.If I choose reconstruction, what is a realistic timeline for my physical recovery, and what are the differences in recovery between implants and tissue flap procedures?
- 5.Is there an optimal age window for me to undergo a preventative mastectomy based on my current health and personal cancer risk?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (10)
- 1
[Prophylactic breast surgery in high-risk breast cancer patients].
Darrigues L, Gaillard T, Sabah J, et al.
Bulletin du cancer 2025; (112(3)):286-299 doi:10.1016/j.bulcan.2025.01.002.
PMID: 39984363 - 2
Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.
Gandhi A, Howell SJ, Harkness EF, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2026; (44(10)):874-882 doi:10.1200/JCO-25-00834.
PMID: 41637687 - 3
Factors Influencing Residual Glandular Breast Tissue after Risk-Reducing Mastectomy in Genetically Predisposed Individuals Detected by MRI Mammography.
Dietzel F, Kolberg L, Vesper AS, et al.
Cancers 2023; (15(3)) doi:10.3390/cancers15030829.
PMID: 36765786 - 4
A BRILLIANT-BRCA study: residual breast tissue after mastectomy and reconstruction.
Kaidar-Person O, Faermann R, Polikar D, et al.
Breast cancer research and treatment 2024; (208(2)):359-367 doi:10.1007/s10549-024-07425-4.
PMID: 38980506 - 5
Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine NE, Lostumbo L, Wallace J, Ko H
The Cochrane database of systematic reviews 2018; (4()):CD002748 doi:10.1002/14651858.CD002748.pub4.
PMID: 29620792 - 6
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Heemskerk-Gerritsen BAM, Jager A, Koppert LB, et al.
Breast cancer research and treatment 2019; (177(3)):723-733 doi:10.1007/s10549-019-05345-2.
PMID: 31302855 - 7
Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
Evans DG, Howell SJ, Howell A
Familial cancer 2019; (18(4)):377-379 doi:10.1007/s10689-019-00142-8.
PMID: 31444676 - 8
Risk-reducing mastectomy in BRCA carriers: survival is not the issue.
Neven P, Punie K, Wildiers H, et al.
Breast cancer research and treatment 2020; (179(1)):251-252 doi:10.1007/s10549-019-05440-4.
PMID: 31541380 - 9
Oncological safety and preventive impact of nipple-sparing mastectomy in patients with BRCA1/2 mutation: multicentre study of the Korea Robot-endoscopy Minimal Access Breast Surgery Study Group (KoREa-BSG).
Kim HK, Shin DS, Jang SY, et al.
BJS open 2025; (10(1)) doi:10.1093/bjsopen/zraf168.
PMID: 41701219 - 10
Immediate Breast Reconstruction with Prepectoral Polyurethane-Covered Implant After Conservative Mastectomy in Large and Ptotic Breasts.
Salgarello M, Fabbri M, Visconti G, et al.
Aesthetic plastic surgery 2025; (49(23)):6555-6564 doi:10.1007/s00266-025-05070-w.
PMID: 40691657
This page provides educational information about preventative mastectomy and breast cancer risk for BRCA carriers. It is not a substitute for professional medical advice. Always discuss your personal cancer risk and surgical options with your healthcare team.
Get notified when new evidence is published on Hereditary breast and/or ovarian cancer syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.